Mindray Medical acquires Datascope’s patient monitoring business

Under the agreement, Mindray has acquired Datascope’s patient monitoring device business for a total purchase price of $209 million in cash, as adjusted for working capital at the closing date. Mindray expects to achieve over $30 million in run-rate synergies from the acquisition in the areas of manufacturing, SG&A and R&D in 2011.

Xu Hang, Mindray’s chairman and co-CEO, said: “This transaction ensures sustainable high growth for our international business and gives us immediate access to an established network of hospital customers in the US. We’re optimistic about the growth potential of our combined business and believe we are now even better positioned to address the growing trend of cost-conscious healthcare spending worldwide.”